Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients

References

• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO.
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125(6):2011–2020. doi:10.1378/chest.125.6.2011.
   PubMed Web of Science ®Google Scholar
• Hickling JK, Jones KR, Friede M, Zehrung D, Chen D, Kristensen D. Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ. 2011;89(3):221–226. doi:10.2471/BLT.10.079426.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Dutz JP. Better influenza vaccines for older people: what will it take? J Infect Dis. 2008;198(5):632–634. doi:10.1086/592362.
   PubMed Web of Science ®Google Scholar
• Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines. 2008;7(8):1201–1214. doi:10.1586/14760584.7.8.1201.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351(22):2286–2294. doi:10.1056/NEJMoa043555.
   PubMed Web of Science ®Google Scholar
• Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis. 2010;50(10):1331–1338. doi:10.1086/652144.
   PubMed Web of Science ®Google Scholar
• Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine. 2010;28(24):4045–4051. doi:10.1016/j.vaccine.2010.04.006.
   PubMed Web of Science ®Google Scholar
• Chuaychoo B, Kositanont U, Rittayamai N, Niyomthong P, Songserm T, Maranetra KN, Rattanasaengloet K, Nana A. The immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic. Hum Vaccin Immunother. 2016;12(7):1728–1737. doi:10.1080/21645515.2016.1149276.
   PubMed Web of Science ®Google Scholar
• Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet. 1979;1(8106):33–35. doi:10.1016/S0140-6736(79)90468-9.
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15(10):1114–1122. doi:10.1016/S0264-410X(97)00003-0.
   PubMed Web of Science ®Google Scholar
• Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Viral Immunol. 2012;25(6):471–476. doi:10.1089/vim.2012.0024.
   PubMed Web of Science ®Google Scholar
• Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J Med Virol. 2007;79(3):320–325. doi:10.1002/(ISSN)1096-9071.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197(4):490–502. doi:10.1086/587088.
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine. 2010;28(23):3929–3935. doi:10.1016/j.vaccine.2010.03.067.
   PubMed Web of Science ®Google Scholar
• Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine. 2007;25(4):659–663. doi:10.1016/j.vaccine.2006.08.026.
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines (CPMP/BWP/214/96). Euro Agency Eval Med Products; 1997 Mar 12. [accessed 2010 Mar 8]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
   Google Scholar
• Gross PA, Russo C, Teplitzky M, Dran S, Cataruozolo P, Munk G. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol. 1996;3:361–362.
   PubMedGoogle Scholar
• Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3.
   PubMed Web of Science ®Google Scholar
• Sagawa M, Kojimahara N, Otsuka N, Kimura M, Yamaguchi N. Immune response to influenza vaccine in the elderly: association with nutritional and physical status. Geriatr Gerontol Int. 2011;11(1):63–68. doi:10.1111/j.1447-0594.2010.00641.x.
   PubMed Web of Science ®Google Scholar
• Arakane R, Nakatani H, Fujisaki E, Takahama A, Ishida K, Yoshiike M, Nakayama T, Takeshita F. Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial. Vaccine. 2015;33(46):6340–6350. doi:10.1016/j.vaccine.2015.09.010.
   PubMed Web of Science ®Google Scholar
• Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong T-Y, Yuen K-Y, et al. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine. 2012;30(45):6427–6435. doi:10.1016/j.vaccine.2012.08.014.
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198(5):650–658. doi:10.1086/592362.
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Hung I, Kenney R. Intradermal vaccination using the novel microneedle device MicronJet600: past, present, and future. Hum Vaccin Immunother. 2015;11(4):991–997. doi:10.1080/21645515.2015.1010871.
   PubMed Web of Science ®Google Scholar
• Plant EP, Fredell LJ, Hatcher BA, Li X, Chiang MJ, Kosikova M, Xie H, Zoueva O, Cost AA, Ye Z, et al. Different repeat annual influenza vaccinations improve the antibody response to drifted influenza strains. Sci Rep. 2017;7(1):5258. doi:10.1038/s41598-017-05579-4.
   PubMedGoogle Scholar
• Trieu MC, Jul-Larsen A, Saevik M, Madsen A, Nostbakken JK, Zhou F, Skrede S, Cox RJ. Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a 5-year follow-up study. Clin Infect Dis. 2019;68(3):382–392. doi:10.1093/cid/ciy487.
   PubMed Web of Science ®Google Scholar
• Leung VKY, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA, Sullivan SG. Influenza vaccination responses: evaluating impact of repeat vaccination among health care workers. Vaccine. 2017;35(19):2558–2568. doi:10.1016/j.vaccine.2017.03.063.
   PubMed Web of Science ®Google Scholar
• Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunol Lett. 2014;162(1):346–353. doi:10.1016/j.imlet.2014.06.006.
   PubMed Web of Science ®Google Scholar
• Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM. Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Hum Vaccin Immunother. 2015;11(3):553–563. doi:10.1080/21645515.2015.1011562.
   PubMed Web of Science ®Google Scholar
• Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli C, Groth N, Levin Y, Del Giudice G, et al. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59(R)-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Hum Vaccin Immunother. 2014;10(6):1701–1710. doi:10.4161/hv.28618.
   PubMed Web of Science ®Google Scholar
• Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38–42. doi:10.1016/j.coi.2014.03.008.
   PubMed Web of Science ®Google Scholar
• Hung IF, Zhang AJ, To KK, Chan JF, Li C, Zhu HS, Li P, Li C, Chan T-C, Cheng VCC, et al. Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial. Clin Infect Dis. 2014;59(9):1246–1255. doi:10.1093/cid/ciu582.
   PubMed Web of Science ®Google Scholar
• Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ, Plotkin SA. Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly. Clin Vaccine Immunol. 2014;21(7):989–996. doi:10.1128/CVI.00615-13.
   PubMedGoogle Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine. 2009;27(52):7304–7312. doi:10.1016/j.vaccine.2009.10.033.
   PubMed Web of Science ®Google Scholar
• Yoo BW, Kim CO, Izu A, Arora AK, Heijnen E. Phase 4, post-marketing safety surveillance of the MF59-adjuvanted influenza vaccines FLUAD(R) and VANTAFLU(R) in South Korean subjects aged >/=65 years. Infect Chemother. 2018;50(4):301–310. doi:10.3947/ic.2018.50.4.301.
   PubMed Web of Science ®Google Scholar